Metformin, Statins Do Not Reduce Incidence of Ovarian Cancer in Women with Type 2 Diabetes, Study Says

Metformin, Statins Do Not Reduce Incidence of Ovarian Cancer in Women with Type 2 Diabetes, Study Says
Women with type 2 diabetes taking metformin or statins are not less likely to develop epithelial ovarian cancer than any other type 2 diabetes patient, a large Finnish cohort study reports. The study, “The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case–control

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *